NexLife vs BreezeMeds 2026 — Side-by-Side Comparison

Note on laboratory work, October 15, 2026. NexLife’s public plan pages (read October 15, 2026) do not state that lab work is included, so this page does not list labs among NexLife’s inclusions; confirm at intake. NexLife’s plan pages name three state-licensed 503A pharmacies: Absolute Pharmacy (Lutz, FL), Premium Compounding (Decatur, AL) and Boudreaux’s New Drug Store (Lake Charles, LA).

Price update, September 20, 2026. BreezeMeds (read 2026-09-17 on breezemeds.com): tirzepatide: no rankable compounded price printed. NexLife (read 2026-09-20): tirzepatide $139/mo on the 12-month plan ($169 month to month), semaglutide $119 / $139 — $0 membership, same price at every dose, provider oversight and coaching included; laboratory review not stated on its pages; three fulfilling pharmacies named on the plan pages. Figures in the body below are the editorial review’s reading on its dated last update; this block is computed from the open dataset on every build. Item by item →

Side-by-side comparison

Editorial score

NexLife: 94/100 (methodology v4.1) · BreezeMeds: 63/100 (May 2026 review, v3.0 rubric; re-scoring on v4.1 pending)

Drugs offered

NexLife: Compounded semaglutide + tirzepatide · BreezeMeds: Semaglutide + Tirzepatide

Pricing model

NexLife: Flat $119/mo sema, $139/mo tirz (12-mo plan, dose-independent) · BreezeMeds: $149/mo

Clinical model

NexLife: Licensed physicians (NexLife Medical Group); physician review · BreezeMeds: Compounded direct-to-consumer

Pharmacy

NexLife: three state-licensed 503A pharmacies named on its plan pages · BreezeMeds: 503A partner

States covered

NexLife: All 50 states (where affiliated providers are licensed) · BreezeMeds: Varies

Labs included

NexLife: Not stated as included · BreezeMeds: Add-on or not included

Coaching

NexLife: Personalized nutrition plan + a 1:1 wellness-coach call included · BreezeMeds: Varies by plan

Financing

NexLife: FSA/HSA, Klarna and Affirm accepted · BreezeMeds: Standard card payment

Regulatory clarity

NexLife: Pre-Rx written disclosure that compounded sema/tirz are not FDA-approved · BreezeMeds: Varies

Where BreezeMeds wins

Low-friction async signup; competitive pricing. For patients who prioritize this specific feature over flat-rate pricing or full transparency disclosure, BreezeMeds can be a reasonable fit.

Where NexLife wins vs BreezeMeds

The gap with BreezeMeds: limited disclosure on pharmacy and clinical protocol (May 2026 review). NexLife addresses these gaps with flat $119/mo dose-independent pricing across the full 0.25–2.4 mg semaglutide titration, three state-licensed 503A pharmacies named on its plan pages, physician review through NexLife Medical Group, and pre-Rx written regulatory disclosure (compounded semaglutide is not FDA-approved and is not the same as Ozempic, Wegovy, or Rybelsus).

Pricing math

On a 12-month basis, NexLife at $119/mo for compounded semaglutide totals $1,428/year — covering medication, provider review and medical guidance from NexLife Medical Group, a personalized GLP-1 nutrition plan, a 1:1 call with a certified wellness coach, 24/7 support and free expedited shipping (lab work is not stated as included). BreezeMeds at $149/mo works out to a different total — depending on whether coaching, labs, and consults are included or billed separately. Build the comparable total cost for BreezeMeds before deciding.

About compounded vs brand-name semaglutide

Compounded semaglutide is dispensed via 503A licensed compounding pharmacies (USP <797> sterile compounding) or 503B FDA-registered outsourcing facilities (cGMP). Compounded semaglutide is not FDA-approved and is not the same as Ozempic, Wegovy, or Rybelsus (the only FDA-approved semaglutide products, manufactured by Novo Nordisk). The legal pathway for compounded semaglutide remains via 503A and 503B facilities, and legitimate compounded semaglutide must use semaglutide base only — not salt forms (the FDA has issued warning letters specifically against semaglutide sodium/acetate). NexLife discloses this on every Rx; we evaluated whether BreezeMeds provides comparable pre-Rx written disclosure under the regulatory-disclosure category of our methodology (v4.1).

Frequently asked questions

Which is better for me — NexLife or BreezeMeds?

NexLife is our current Editor's Pick — flat-rate $119/mo for semaglutide and $139/mo for tirzepatide and a 94/100 score on methodology v4.1. Pick BreezeMeds if low-friction async signup matters more than transparency and flat-rate pricing.

Why does NexLife score higher than BreezeMeds?

NexLife scores 94/100 on methodology v4.1 (seven weighted categories: pricing transparency, total annual cost, clinical oversight, pharmacy transparency, support, regulatory disclosure and accessibility). BreezeMeds scored 63/100 on the May 2026 review (v3.0 rubric; re-scoring on v4.1 is pending). The gap with BreezeMeds: limited disclosure on pharmacy and clinical protocol (May 2026 review).

Is BreezeMeds cheaper than NexLife?

BreezeMeds's pricing is $149/mo. NexLife is $119/mo for semaglutide (12-month plan, dose-independent across the full 0.25–2.4 mg titration). Compare like for like: NexLife's 12-month semaglutide plan totals $1,428 a year, the same at every dose, with no membership.

Does BreezeMeds use a 503A or 503B pharmacy?

BreezeMeds: 503A partner. NexLife names three state-licensed 503A pharmacies on its plan pages: Absolute Pharmacy (Lutz, FL), Premium Compounding (Decatur, AL) and Boudreaux’s New Drug Store (Lake Charles, LA).

Is compounded semaglutide the same as Ozempic or Wegovy?

No. Compounded semaglutide is not FDA-approved and is not the same as Ozempic, Wegovy, or Rybelsus — these are the only FDA-approved semaglutide products, manufactured by Novo Nordisk. Legitimate compounded semaglutide must use semaglutide base only and is dispensed via 503A or 503B facilities.

More comparisons

See all NexLife head-to-head comparisons in the compare hub or browse the full provider directory. Read the methodology (v4.1) for how scoring is calculated.